Soloway Thomas M — SEC insider filings
SEC reporting owner CIK 1454280. 9 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-12-07 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Third Harmonic Bio, Inc. (THRD) | Director | 5 | — | — | 8 |
| Satsuma Pharmaceuticals, Inc. (STSA) | Director | 3 | — | — | 5 |
| Azora Therapeutics, Inc. (DE) (AZR) | Director | 1 | — | — | — |
Insider filings — Soloway Thomas M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 3 | Azora Therapeutics, Inc. (DE) (AZR) | Holdings only — no transactions reported | EDGAR |
| 2025-08-14 | 4 | Third Harmonic Bio, Inc. (THRD) | Other (J): 120,166 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Satsuma Pharmaceuticals, Inc. (STSA) | Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Third Harmonic Bio, Inc. (THRD) | Disposition to issuer (D): 76,582 (derivative) · Grant/award (A): 76,582 (derivative) · Disposition to issuer (D): 13,667 (derivative) · Grant/award (A): 13,667 (derivative) | EDGAR |
| 2022-10-27 | 4 | Third Harmonic Bio, Inc. (THRD) | Grant/award (A): 13,667 (derivative) @ $0 | EDGAR |
| 2022-06-07 | 4 | Satsuma Pharmaceuticals, Inc. (STSA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2020-12-07 | 4 | Satsuma Pharmaceuticals, Inc. (STSA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1454280 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs